🧪 Beta — BiohacksAI is under active development. Data and features may change.
B
BiohacksAI
Evidence-Based Biohacking
BetaPatent Pending

Nan 190

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Nan 190, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

way
5 shared targets
bmy
4 shared targets
naftopidil
3 shared targets
cyclazosin
3 shared targets
ipsapirone
5 shared targets
rauwolscine
4 shared targets
alfuzosin
3 shared targets
nortopsentin
2 shared targets
bromotopsentin
2 shared targets
nortopsentin
2 shared targets
Loading evidence profile...

This evidence profile for Nan 190 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.